Literature DB >> 23568552

Pleiotropic actions of amiodarone: still puzzling after half a century.

Jordi Heijman, Dobromir Dobrev.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23568552     DOI： 10.1007/s00210-013-0865-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  34 in total

1.  Dronedarone in atrial fibrillation--Jekyll and Hyde?

Authors:  Stanley Nattel
Journal:  N Engl J Med       Date:  2011-11-14       Impact factor: 91.245

2.  Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation?

Authors:  Joachim R Ehrlich; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-04       Impact factor: 3.000

Review 3.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

Review 4.  The emerging role of amiodarone and dronedarone in Chagas disease.

Authors:  Gustavo Benaim; Alberto E Paniz Mondolfi
Journal:  Nat Rev Cardiol       Date:  2012-08-07       Impact factor: 32.419

5.  Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.

Authors:  Saurav Chatterjee; Joydeep Ghosh; Edgar Lichstein; Shamik Aikat; Debabrata Mukherjee
Journal:  Am J Cardiol       Date:  2012-05-19       Impact factor: 2.778

6.  Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.

Authors:  Haruyasu Ito; Koh Ono; Ryousuke Nishio; Shigetake Sasayama; Akira Matsumori
Journal:  Cytokine       Date:  2002-02-21       Impact factor: 3.861

7.  Local venous response to N-desethylamiodarone in humans.

Authors:  M Grossmann; D Dobrev; H M Himmel; W Kirch
Journal:  Clin Pharmacol Ther       Date:  2000-01       Impact factor: 6.875

8.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.

Authors:  Constanze Schmidt; Felix Wiedmann; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-13       Impact factor: 3.000

10.  Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

Authors:  Andreas Goette; Alicja Bukowska; Dobromir Dobrev; Jan Pfeiffenberger; Henning Morawietz; Denis Strugala; Ingrid Wiswedel; Friedrich-Wilhelm Röhl; Carmen Wolke; Sybille Bergmann; Peter Bramlage; Ursula Ravens; Uwe Lendeckel
Journal:  Eur Heart J       Date:  2009-03-05       Impact factor: 29.983
View more
  6 in total

Review 1.  [Cardiovascular pharmacotherapy. Risks and adverse effects].

Authors:  N Voigt; J Heijman; D Dobrev
Journal:  Herz       Date:  2014-03       Impact factor: 1.443

2.  Mechanisms underlying drug-mediated regulation of membrane protein function.

Authors:  Radda Rusinova; Changhao He; Olaf S Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-16       Impact factor: 11.205

3.  The class III anti-arrhythmic agent, amiodarone, inhibits voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells.

Authors:  Hongliang Li; Han Sol Kim; Hye Won Kim; Sung Eun Shin; Won-Kyo Jung; Kwon-Soo Ha; Eun-Taek Han; Seok-Ho Hong; Amy L Firth; Young Min Bae; Il-Whan Choi; Won Sun Park
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-31       Impact factor: 3.000

4.  Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation.

Authors:  Jordi Heijman; Gerd Heusch; Dobromir Dobrev
Journal:  Clin Med Insights Cardiol       Date:  2013-08-11

5.  Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts.

Authors:  Aneesh V Karkhanis; Gopalakrishnan Venkatesan; Ryuichi Kambayashi; Jacqueline Wen Hui Leow; Marcus Qingrui Han; Hiroko Izumi-Nakaseko; Ai Goto; Jeremy Kah Sheng Pang; Boon Seng Soh; Pipin Kojodjojo; Atsushi Sugiyama; Eric Chun Yong Chan
Journal:  Acta Pharm Sin B       Date:  2022-03-16       Impact factor: 14.903

6.  Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Authors:  Fabian Sanchis-Gomar; Carl J Lavie; Daniel P Morin; Carme Perez-Quilis; Jari A Laukkanen; Marco V Perez
Journal:  Am J Cardiovasc Drugs       Date:  2020-10       Impact factor: 3.283
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.